KEYMED BIO-B

2162
69.0001.22% ( -0.850 )
Delay Closed: Nov 16, 16:08:11

Financials

H1 2026 Earnings

Financial report interval: 2025.12.30 - 2026.06.30

Overview: KEYMED BIO-B(02162) the Revenue is 712.74 M (--%), Beat estimate;the EBIT is -166.74 M (--%), Beat estimate;the EPS is 4.91 (--%), Miss estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.71B--
0.71B--
+0.00B--%
EBITExceed expectations
-0.17B--
-0.26B--
+0.10B--%
EPSMiss expectations
4.9089--
5.3132--
-0.4043--%

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateNov 20, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly